Lessons of the month 1: Salbutamol induced lactic acidosis: clinically recognised but often forgotten
Author(s) -
Laurence Pearmain,
Ravi Gupta,
R.J. Bright-Thomas
Publication year - 2020
Publication title -
clinical medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.531
H-Index - 56
eISSN - 1473-4893
pISSN - 1470-2118
DOI - 10.7861/clinmed.2019-0271
Subject(s) - medicine , lactic acidosis , salbutamol , context (archaeology) , wheeze , acidosis , polypharmacy , anesthesia , intensive care medicine , asthma , metabolic acidosis , paleontology , biology
We present the case of an 83-year-old woman, with known asthma, admitted with increasing dyspnoea, wheeze and a productive cough. In addition to maintenance inhaled therapy, the patient was also on long-term mirtazapine and furosemide. Following acute treatment with nebulised salbutamol she became increasingly dyspnoeic and developed a metabolic acidosis with a significantly raised blood lactate level. After cessation of ß 2 -adrenergic medication, the patient's clinical condition improved with resolution of her lactic acidosis; salbutamol induced lactic acidosis was diagnosed. This clinical scenario is common but not well described. Here we discuss the mechanisms, investigation and management of raised serum lactate and lactic acidosis in the context of acute asthma and the possible interactions of polypharmacy and comorbidities in the acute medical setting.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom